Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Nataraj Balakrishnan, Gurunathan Baskar, Sathyanarayan Balaji, Malathi Kullappan & Surapaneni Krishna Mohan. (2022) Machine learning modeling to identify affinity improved biobetter anticancer drug trastuzumab and the insight of molecular recognition of trastuzumab towards its antigen HER2. Journal of Biomolecular Structure and Dynamics 40:22, pages 11638-11652.
Read now
Read now
Lidia Rita Corsini, Daniele Fanale, Francesco Passiglia, Lorena Incorvaia, Vincenzo Gennusa, Viviana Bazan & Antonio Russo. (2018) Monoclonal antibodies for the treatment of non-hematological tumors: a safety review. Expert Opinion on Drug Safety 17:12, pages 1197-1209.
Read now
Read now
Xiaomin Fu, Yong Zhang, Jing Yang, Yalong Qi, Yue Ming, Miaomiao Sun, Yiman Shang, Yonghao Yang, Xiaoyan Zhu & Quanli Gao. (2018) Efficacy and safety of trastuzumab as maintenance or palliative therapy in advanced HER2-positive gastric cancer. OncoTargets and Therapy 11, pages 6091-6100.
Read now
Read now
Carmela Coppola, Gennaro Riccio, Antonio Barbieri, Maria Gaia Monti, Giovanna Piscopo, Domenica Rea, Claudio Arra, Carlo Maurea, Claudia De Lorenzo & Nicola Maurea. (2016) Antineoplastic-related cardiotoxicity, morphofunctional aspects in a murine model: contribution of the new tool 2D-speckle tracking. OncoTargets and Therapy 9, pages 6785-6794.
Read now
Read now
Articles from other publishers (39)
Seung Yon Han, Jeong-Eun Yu, Byoung Hoon You, Seo-Yeon Kim, Mingoo Bae, Hee-Sung Chae, Young-Won Chin, Soo-Hwa Hong, Ju-Hee Lee, Seung Hyun Jung & Young Hee Choi. (2023) No Interference of H9 Extract on Trastuzumab Pharmacokinetics in Their Combinations. International Journal of Molecular Sciences 24:23, pages 16677.
Crossref
Crossref
Nanthip Prathumsap, Benjamin Ongnok, Thawatchai Khuanjing, Apiwan Arinno, Chayodom Maneechote, Titikorn Chunchai, Busarin Arunsak, Sasiwan Kerdphoo, Siriporn C. Chattipakorn & Nipon Chattipakorn. (2023) Acetylcholine receptor agonists effectively attenuated multiple program cell death pathways and improved left ventricular function in trastuzumab-induced cardiotoxicity in rats. Life Sciences 329, pages 121971.
Crossref
Crossref
Suprava Shah, Rakesh Narang, Vikram Jeet Singh, Govindaiah Pilli & Surendra Kumar Nayak. (2023) A Review on Anticancer Profile of Flavonoids: Sources, Chemistry,
Mechanisms, Structure-activity Relationship and Anticancer Activity. Current Drug Research Reviews 15:2, pages 122-148.
Crossref
Crossref
Mengjia Chen, Jianing Xue, Maoling Wang, Junyao Yang & Ting Chen. (2023) Cardiovascular Complications of Pan-Cancer Therapies: The Need for Cardio-Oncology. Cancers 15:11, pages 3055.
Crossref
Crossref
René R Sevag Packard. (2022) Cardiac fibrosis in oncologic therapies. Current Opinion in Physiology 29, pages 100575.
Crossref
Crossref
Serena L’Abbate, Michela Chianca, Iacopo Fabiani, Annamaria Del Franco, Alberto Giannoni, Giuseppe Vergaro, Chrysanthos Grigoratos, Claudia Kusmic, Claudio Passino, Yuri D’Alessandra, Silvia Burchielli, Michele Emdin & Daniela Maria Cardinale. (2022) In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation. Journal of Cardiovascular Translational Research 15:5, pages 1143-1162.
Crossref
Crossref
Chenchen Meng, Lu Fan, Xiaoming Wang, Yunjiao Wang, Yanyang Li, Shuchao Pang, Shichao Lv & Junping Zhang. (2022) Preparation and Evaluation of Animal Models of Cardiotoxicity in Antineoplastic Therapy. Oxidative Medicine and Cellular Longevity 2022, pages 1-16.
Crossref
Crossref
Efstratios Koutroumpakis, Nikhil Agrawal, Nicolas L. Palaskas, Jun-ichi Abe, Cezar Iliescu, Syed Wamique Yusuf & Anita Deswal. (2022) Myocardial Dysfunction in Patients with Cancer. Heart Failure Clinics 18:3, pages 361-374.
Crossref
Crossref
Michela Pecoraro, Stefania Marzocco, Silvia Franceschelli & Ada Popolo. (2022) Trastuzumab and Doxorubicin Sequential Administration Increases Oxidative Stress and Phosphorylation of Connexin 43 on Ser368. International Journal of Molecular Sciences 23:12, pages 6375.
Crossref
Crossref
Qinchao Wu, Baochen Bai, Chao Tian, Daisong Li, Haichu Yu, Bingxue Song, Bing Li & Xianming Chu. (2021) The Molecular Mechanisms of Cardiotoxicity Induced by HER2, VEGF, and Tyrosine Kinase Inhibitors: an Updated Review. Cardiovascular Drugs and Therapy 36:3, pages 511-524.
Crossref
Crossref
Swaraj Mohanty & Yasmin Ahmad. 2022. Cardiovascular toxicity and therapeutic modalities targeting cardio-oncology. Cardiovascular toxicity and therapeutic modalities targeting cardio-oncology
65
82
.
Muhammad Mustafa Alhussein, Abir Mokbel, Tammy Cosman, Nazanin Aghel, Eric H. Yang, Som D. Mukherjee, Susan Dent, Peter M. Ellis, Sukhbinder Dhesy-Thind & Darryl P. Leong. (2021) Pertuzumab Cardiotoxicity in Patients With HER2-Positive Cancer: A Systematic Review and Meta-analysis. CJC Open 3:11, pages 1372-1382.
Crossref
Crossref
Lynn Htet Htet Aung, Xiatian Chen, Juan Carlos Cueva Jumbo, Zhe Li, Shao-ying Wang, Cheng Zhao, Ziqian Liu, Yin Wang & Peifeng Li. (2021) Cardiomyocyte mitochondrial dynamic-related lncRNA 1 (CMDL-1) may serve as a potential therapeutic target in doxorubicin cardiotoxicity. Molecular Therapy - Nucleic Acids 25, pages 638-651.
Crossref
Crossref
Miguel Anjos, Marta Fontes-Oliveira, Vera M. Costa, Mário Santos & Rita Ferreira. (2021) An update of the molecular mechanisms underlying doxorubicin plus trastuzumab induced cardiotoxicity. Life Sciences 280, pages 119760.
Crossref
Crossref
Salma B. Abdelbaky, Mayar Tarek Ibrahim, Hebatallah Samy, Menatalla Mohamed, Hebatallah Mohamed, Mahmoud Mustafa, Moustafa M. Abdelaziz, M. Laird Forrest & Islam A. Khalil. (2021) Cancer immunotherapy from biology to nanomedicine. Journal of Controlled Release 336, pages 410-432.
Crossref
Crossref
Tsuyoshi SHIGA, Takako KAMIO, Kenta UTO & Kotaro ARAI. (2021) Successful Use of Digoxin for Trastuzumab-related Cardiotoxicity to Facilitate Breast Surgery in a Patient with Metastatic Breast Cancer. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 52:4, pages 101-105.
Crossref
Crossref
Michela Pecoraro, Aldo Pinto & Ada Popolo. (2020) Trastuzumab-induced cardiotoxicity and role of mitochondrial connexin43 in the adaptive response. Toxicology in Vitro 67, pages 104926.
Crossref
Crossref
Bahman Moradipoodeh, Mostafa Jamalan, Majid Zeinali, Masood Fereidoonnezhad & Ghorban Mohammadzadeh. (2020) Specific targeting of HER2-positive human breast carcinoma SK-BR-3 cells by amygdaline-ZHER2 affibody conjugate. Molecular Biology Reports 47:9, pages 7139-7151.
Crossref
Crossref
Nathalie I. Bouwer, Agnes Jager, Crista Liesting, Marcel J.M. Kofflard, Jasper J. Brugts, Jos J.E.M. Kitzen, Eric Boersma & Mark-David Levin. (2020) Cardiac monitoring in HER2-positive patients on trastuzumab treatment: A review and implications for clinical practice. The Breast 52, pages 33-44.
Crossref
Crossref
José Isaac Alves de Andrade, Daniel Pinheiro Fernandes, Ingrid Yanne Gomes Ferreira, Letícia Rodrigues de Abrantes & Danielle Rocha Silva. (2020) ESTUDO DA CARDIOTOXICIDADE INDUZIDA PELO TRASTUZUMAB NA TERAPIA DO CÂNCER DE MAMA HER2 POSITIVO. Revista interdisciplinar em saúde 7:Único, pages 620-635.
Crossref
Crossref
Gizem Tugce Ulu, Yagmur Kiraz & Yusuf Baran. 2020. Biodiversity and Biomedicine. Biodiversity and Biomedicine
441
457
.
V. Quagliariello, M. Passariello, C. Coppola, D. Rea, A. Barbieri, M. Scherillo, M.G. Monti, R.V. Iaffaioli, M. De Laurentiis, P.A. Ascierto, G. Botti, C. De Lorenzo & N. Maurea. (2019) Cardiotoxicity and pro-inflammatory effects of the immune checkpoint inhibitor Pembrolizumab associated to Trastuzumab. International Journal of Cardiology 292, pages 171-179.
Crossref
Crossref
Julia B. Blanter & William H. Frishman. (2019) The Preventive Role of Angiotensin Converting Enzyme Inhibitors/Angiotensin-II Receptor Blockers and β-Adrenergic Blockers in Anthracycline- and Trastuzumab-Induced Cardiotoxicity. Cardiology in Review 27:5, pages 256-259.
Crossref
Crossref
Xiaonan Zhang, Yaping Zhu, Shaoyang Dong, Ao Zhang, Yanmin Lu, Yanyang Li, Shichao Lv & Junping Zhang. (2019) Role of oxidative stress in cardiotoxicity of antineoplastic drugs. Life Sciences 232, pages 116526.
Crossref
Crossref
Margherita Passariello, Simona Camorani, Cinzia Vetrei, Laura Cerchia & Claudia De Lorenzo. (2019) Novel Human Bispecific Aptamer–Antibody Conjugates for Efficient Cancer Cell Killing. Cancers 11:9, pages 1268.
Crossref
Crossref
Hyun Ju Yoon, Kye Hun Kim, Hyung Yoon Kim, Hyukjin Park, Jae Yeong Cho, Young Joon Hong, Hyung Wook Park, Ju Han Kim, Youngkeun Ahn, Myung Ho Jeong, Jeong Gwan Cho & Jong Chun Park. (2019) Impacts of non-recovery of trastuzumab-induced cardiomyopathy on clinical outcomes in patients with breast cancer. Clinical Research in Cardiology 108:8, pages 892-900.
Crossref
Crossref
Pierantonio Menna, Giorgio Minotti & Emanuela Salvatorelli. (2019) Cardiotoxicity of Targeted Cancer Drugs: Concerns, “The Cart Before the Horse,” and Lessons from Trastuzumab. Current Cardiology Reports 21:5.
Crossref
Crossref
Gennaro Riccio, Ana Rita Ricardo, Margherita Passariello, Kathy Saraiva, Valentina Rubino, Philip Cunnah, Nico Mertens & Claudia De Lorenzo. (2019) T-cell Activating Tribodies as a Novel Approach for Efficient Killing of ErbB2-positive Cancer Cells. Journal of Immunotherapy 42:1, pages 1-10.
Crossref
Crossref
Avirup Guha, Merna Armanious & Michael G. Fradley. (2019) Update on cardio-oncology: Novel cancer therapeutics and associated cardiotoxicities. Trends in Cardiovascular Medicine 29:1, pages 29-39.
Crossref
Crossref
Tatiane Catleia Melo dos Santos e Silva, Meire Cristina Novelli Castro & Regina Célia Popim. (2018) Adaptation of the Nursing Activities Score for oncologic care. Revista Brasileira de Enfermagem 71:5, pages 2383-2391.
Crossref
Crossref
Nishant Mohan, Jiangsong Jiang, Milos Dokmanovic & Wen Jin Wu. (2018) Trastuzumab-mediated cardiotoxicity: current understanding, challenges, and frontiers. Antibody Therapeutics 1:1, pages 13-17.
Crossref
Crossref
N. A. Kozyavin & T. Yu. Semiglazova. (2018) PREVENTION AND MONITORING OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH LUMINAL HER2-NEGATIVE METASTATIC BREAST CANCER. Tumors of female reproductive system 14:2, pages 61-71.
Crossref
Crossref
Christian Cadeddu Dessalvi, Martino Deidda, Donato Mele, Pier P. Bassareo, Roberta Esposito, Ciro Santoro, Maria Lembo, Maurizio Galderisi & Giuseppe Mercuro. (2018) Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention. Journal of Cardiovascular Medicine 19:7, pages 315-323.
Crossref
Crossref
Luciana L. Ferreira, Ana Raquel Coelho, Paulo J. Oliveira & Teresa Cunha-Oliveira. 2018. Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants. Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants
593
612
.
Gilbert Bustamante, Bingzhi Wang, Lu-Zhe Sun, Jing Yong Ye & Frank DeLuna. (2018) In-vivo fluorescence detection of breast cancer growth factor receptors by fiber-optic probe. In-vivo fluorescence detection of breast cancer growth factor receptors by fiber-optic probe.
Stefania Gorini, Antonella De Angelis, Liberato Berrino, Natalia Malara, Giuseppe Rosano & Elisabetta Ferraro. (2018) Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib. Oxidative Medicine and Cellular Longevity 2018, pages 1-15.
Crossref
Crossref
Nana Gegechkori, Lindsay Haines & Jenny J. Lin. (2017) Long-Term and Latent Side Effects of Specific Cancer Types. Medical Clinics of North America 101:6, pages 1053-1073.
Crossref
Crossref
Tochi M Okwuosa, Sarah Anzevino & Ruta Rao. (2017) Cardiovascular disease in cancer survivors. Postgraduate Medical Journal 93:1096, pages 82-90.
Crossref
Crossref
N. Maurea, C. Coppola & A. Rienzo. 2017. Anti-Cancer Treatments and Cardiotoxicity. Anti-Cancer Treatments and Cardiotoxicity
55
72
.